India Life Sciences Expansion: Proven Strategies for Growth
India life sciences expansion is accelerating with Cotecna's acquisition of Energon Labs, enhancing their market presence.
Category: pharma
Are GLP-1 Compounding Agents Safe? Proven Issues Found
GLP-1 compounding agents have been linked to serious safety concerns due to black mould and bugs found in Chinese plants.
Cancer drug price cap: Is it the best solution for patients?
Cancer drug price cap aims to provide relief for patients needing affordable medication.
Lipocine stock surge: Proven boost after Health Canada approval
Lipocine stock surge highlights a proven increase following Health Canada's drug approval.
Karnataka hospital medicine prices: What’s the real cost?
Karnataka hospital medicine prices are up to 52 times higher. Discover the implications for patients and healthcare access.
HUTCHMED lung cancer drug: Proven Approval Process
HUTCHMED lung cancer drug seeks FDA approval with AstraZeneca's filing.
Type 2 Diabetes Pipeline: What Are the Best Proven Treatments?
Type 2 Diabetes Pipeline highlights the latest FDA approvals and clinical advancements for 2026.
Lilly stock breast cancer drug approval: A Smart Move
Lilly stock breast cancer drug approval signifies potential growth for shareholders and investors in the pharma industry.
Is the Abortion Pill South Korea’s Best Proven Option This Year?
Abortion pill South Korea is nearing approval, offering a safe choice for women seeking reproductive health solutions this year.